Penile Carcinoma: Clinical Trials

2 trials for Penile Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Penile Carcinoma: new trials by email Literature Review of Penile Carcinoma trials Research Report on Penile Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma
Dostarlimab, Niraparib - Penile Carcinoma
Phase 2RecruitingH. Lee Moffitt Cancer Center and Research Institute252022-12-282025-12-04
Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer
Pembrolizumab, Standard of care therapy - Penile Carcinoma
Phase 2CompletedLatin American Cooperative Oncology Group372020-06-152024-03-13

Narrower conditions

Penile Neoplasms (2)

Broader conditions

Genital Diseases (2)  ·  Genital Diseases, Male (2)  ·  Genital Neoplasms, Male (2)  ·  Male Urogenital Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Penile Diseases (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)

Interventions

dostarlimab (1)  ·  niraparib (1)  ·  pembrolizumab (1)

Sponsors

H. Lee Moffitt Cancer Center and Research Institute (1)  ·  Latin American Cooperative Oncology Group (1)

Countries

Brazil (1)  ·  United States (1)

Top investigators

Fernando Cotait Maluf (1)  ·  Juskaran Chadha, DO (1)

Results publications

PMID 40965911, PMID 41163621